Shanghai ZhiBei Information Consulting Co., Ltd

Products

SARS-CoV-2 Ab rapid test


Keywords :

COVID-19 / RT-PCR Detection Kit / IgG/IgM Rapid Test


  • Hits : 289
  • Company : Shanghai ZhiBei Information Consulting Co., Ltd
  • Telephone : +86 18930727028
Contact Us

Product Details

Contact Us

Five Advantages Of Products

  • Lateral Flow Test - suitable for rapid, on-site testing
  • Performance: sensitivity of 94.70% (125/132) and specificity of 98.89% (268/271). The test has been clinically validated during the 2020 COVID-19 outbreak in China
  • Easy-to-use: No special equipment. Works with whole blood, serum or plasma samples
  • Fast: clear answer within only 15 minutes
  • Easy-to-use: No special equipment. Works with whole blood, serum or plasma samples

Product Details

Wantai SARS-CoV-2 total antibody rapidtest is intended for screening of patientssuspected for infection with theSARS-CoV-2 virus, an aid in the diagnosisof the COVID-19 disease


Test Procedure

1. Prepare the Test 

Allow the test cassette to reach roomtemperature, use it within 20 minutesafter opening the pouch.

2. Add the Specimen 

Add 10μl of whole blood, serum or plasma specimenAdd two drops of Diluent Buffer.

3. Read Result

Read the results at 15 min.


Advanced Diagnostic Technology

01 Lateral Flow Test - suitable for rapid, on-site testing

02 Performance: sensitivity of 94.70% (125/132) and specificity of 98.89% (268/271). The test has been clinically validated during the 2020 COVID-19 outbreak in China

03 Easy-to-use: No special equipment. Works with whole blood, serum or plasma samples

04  Fast: clear answer within only 15 minutes

Shanghai ZhiBei Information Consulting Co., Ltd

Contact Person: Hunter Wang

Telephone: +86 18930727028

Landline: +86 18930727028

Company Address: Room 1603, Building 26,Lane 100,Chujia Road, Qingcun Town, Fengxian District, Shanghai, China

Factory Address:  Room 1603, Building 26,Lane 100,Chujia Road, Qingcun Town, Fengxian District, Shanghai, China

Website: www.zhibeimas.com

Previous: 2019-nCoV IgMIgG Antibody Combo T...

Next: No

Inquiry :

Inquiry